Michael D Loberg - Net Worth and Insider Trading
Michael D Loberg Net Worth
The estimated net worth of Michael D Loberg is at least $3 Million dollars as of 2024-03-28. Michael D Loberg is the Director of Arqule Inc and owns about 132,142 shares of Arqule Inc (ARQL) stock worth over $3 Million. Michael D Loberg is also the Director of IGM Biosciences Inc and owns about 72,627 shares of IGM Biosciences Inc (IGMS) stock worth over $700,851. Details can be seen in Michael D Loberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael D Loberg has not made any transactions after 2022-09-28 and currently still holds the listed stock(s).
Transaction Summary of Michael D Loberg
Michael D Loberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael D Loberg owns 3 companies in total, including IGM Biosciences Inc () , Arqule Inc () , and AMAG Pharmaceuticals Inc () .
Click here to see the complete history of Michael D Loberg’s form 4 insider trades.
Insider Ownership Summary of Michael D Loberg
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
IGM Biosciences Inc | 2022-09-28 | director | |
Arqule Inc | 2020-01-16 | director | |
AMAG Pharmaceuticals Inc | 2008-12-19 | director |
Michael D Loberg Latest Holdings Summary
Michael D Loberg currently owns a total of 2 stocks. Among these stocks, Michael D Loberg owns 132,142 shares of Arqule Inc (ARQL) as of December 17, 2015, with a value of $3 Million and a weighting of 79.04%. Michael D Loberg also owns 72,627 shares of IGM Biosciences Inc (IGMS) as of September 28, 2022, with a value of $700,851 and a weighting of 20.96%.
Latest Holdings of Michael D Loberg
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ARQL | Arqule Inc | 2015-12-17 | 132,142 | 20.00 | 2,642,840 |
IGMS | IGM Biosciences Inc | 2022-09-28 | 72,627 | 9.65 | 700,851 |
Holding Weightings of Michael D Loberg
Michael D Loberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael D Loberg has made a total of 0 transactions in Arqule Inc (ARQL) over the past 5 years. The most-recent trade in Arqule Inc is the acquisition of 3,719 shares on December 17, 2015, which cost Michael D Loberg around $8,033.
According to the SEC Form 4 filings, Michael D Loberg has made a total of 3 transactions in IGM Biosciences Inc (IGMS) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in IGM Biosciences Inc is the acquisition of 6,679 shares on September 28, 2022, which cost Michael D Loberg around $139,524.
Insider Trading History of Michael D Loberg
- 1
Michael D Loberg Trading Performance
GuruFocus tracks the stock performance after each of Michael D Loberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael D Loberg is -9.21%. GuruFocus also compares Michael D Loberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael D Loberg within 3 months outperforms 15 times out of 44 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael D Loberg's insider trading performs compared to the benchmark.
Performance of Michael D Loberg
Average Relative Return
-0.35%
Outperforming Transactions
41%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Relative Return(%) | -1.8 | -9.21 | -9.81 | -0.35 | 3.09 | 8.29 |
Relative Return to S&P 500(%) | -0.6 | -4.85 | -3.3 | 6.68 | 0.45 | 4.03 |
Michael D Loberg Ownership Network
Ownership Network List of Michael D Loberg
Ownership Network Relation of Michael D Loberg
Michael D Loberg Owned Company Details
What does IGM Biosciences Inc do?
Who are the key executives at IGM Biosciences Inc?
Michael D Loberg is the director of IGM Biosciences Inc. Other key executives at IGM Biosciences Inc include Principal Accounting Officer Steven Weber , Chief Medical Officer Chris H Takimoto , and Chief Financial Officer Misbah Tahir .
IGM Biosciences Inc () Insider Trades Summary
Over the past 18 months, Michael D Loberg made no insider transaction in IGM Biosciences Inc (). Other recent insider transactions involving IGM Biosciences Inc () include a net sale of 45,975 shares made by Bruce Keyt , a net sale of 11,918 shares made by George Gauthier , and a net sale of 14,987 shares made by Lisa Lynn Decker .
In summary, during the past 3 months, insiders sold 28,125 shares of IGM Biosciences Inc () in total and bought 0 shares, with a net sale of 28,125 shares. During the past 18 months, 229,745 shares of IGM Biosciences Inc () were sold and 795,616 shares were bought by its insiders, resulting in a net purchase of 565,871 shares.
IGM Biosciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
IGM Biosciences Inc Insider Transactions
Michael D Loberg Mailing Address
Above is the net worth, insider trading, and ownership report for Michael D Loberg. You might contact Michael D Loberg via mailing address: C/o Arqule, Inc., 1 Wall Street, 6th Floor, Burlington Ma 01803.